Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06739239Recruiting

French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR

Role: collaborator

NCT06679491Not ApplicableRecruiting

Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes

Role: lead

NCT05090241Completed

Frailty Prevention in Elders From Reunion Island

Role: lead

NCT06077084Not ApplicableCompleted

Neck Strengthening in Non-Specific Chronic Neck Pain

Role: lead

NCT05604339Completed

Study of Recovery and Blood Rheology Changes in Ultra-endurance Runners (ERUPTION-3)

Role: collaborator

NCT05953558Recruiting

French Cohort Evaluating the effectiveneSs of Atrioventricular Synchrony by the micRa AV

Role: collaborator

NCT01794377Not ApplicableCompleted

Influence of Muscle Strength on the Energy Cost of Walking in Obese Subjects

Role: collaborator

All 7 trials loaded